The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
In this session, Dennis Black and Dennis Orthman share their experiences and best practices to improve and expand the provider-supplier relationship.
On-Demand Educational Webinars
In order to become data-driven organizations, healthcare providers need to leverage data standards and information technology.
Webcast
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor
On-Demand Educational Webinars
New risk sharing models align the economics of an agreement to product or service performance and outcomes. In this webinar, we discuss this…
Podcasts
A short introduction to the CMS Meaningful Use 3 Rule and how implementing UDI within the healthcare setting and moving toward the full GS1 will re